https://charts.traderzeitung.de/phases/US8902608392 string(1455) "{"isin":"US8902608392","name":"Tonix Pharmaceuticals Holding Corp","stock_id_xnas":72754804,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":11.095,"close_at":"2026-09-21 15:20:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":10.69,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":-3.6503},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":10.94,"close_at":"2026-09-22 15:25:00","complete":true,"perf_pct":2.3386},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":10.61,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":-3.0165},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":10.25,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-3.393},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Tonix Pharmaceuticals Holding Aktie News & Nachrichten

[WKN: A40VM0 | Symbol: TNXP]

Realtimekurs

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Tonix Pharmaceuticals Holding gefunden werden.

Tonix Pharmaceuticals Holding Nachrichtenticker öffnen

MT Newswires 13.07.2026 14:01 Uhr

Tonix Pharmaceuticals erreicht Medicare-Versorgungsvereinbarung für Fibromyalgie-Behandlung

08:00 AM EDT, 07/13/2026 (MT Newswires) -- Tonix Pharmaceuticals (TNXP) hat eine Managed-Medicare-Vereinbarung für seine Fibromyalgie-Therapie Tonmya

MT Newswires 29.06.2026 14:16 Uhr

Tonix Pharmaceuticals treibt TNX-102 SL in Phase-2-MDD-Studie voran

08:15 AM EDT, 06/29/2026 (MT Newswires) -- Tonix Pharmaceuticals (TNXP) hat den ersten Patienten in ihre Phase-2-Horizon-Studie eingeschrieben, die TN

MT Newswires 25.06.2026 13:38 Uhr

Raymond James nimmt die Berichterstattung über Tonix Pharmaceuticals mit einem "Strong Buy"-Rating und einem Kursziel von 26 $ auf

07:36 AM EDT, 06/25/2026 (MT Newswires) -- Tonix Pharmaceuticals Holding (TNXP) hat laut von FactSet befragten Analysten ein durchschnittliches "Buy"-

MT Newswires 08.06.2026 14:25 Uhr

Tonix Pharmaceuticals schließt zweiten kommerziellen Kostenträgervertrag ab, erweitert Medikamentenabdeckung

08:24 AM EDT, 06/08/2026 (MT Newswires) -- Tonix Pharmaceuticals (TNXP) teilte am Montag mit, ein Abkommen mit einer zweiten großen Einkaufsorganisati